Anna Svarna

6PUBLICATIONS
16CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Mar 27, 2026
Molecular Profiling and Treatment Outcomes in Uterine Serous Carcinoma: Prognostic Role of Estrogen Receptor Expression.

Anna Svarna, Michalis Liontos, Kallirroi Goula

|Nov 27, 2025
Epigenetics in Ovarian Cancer: A Review of Current Knowledge and Future Perspectives.

Nikolaos Dedes, Michalis Liontos, Dimitrios Haidopoulos

|May 27, 2025
Molecular Prognostic Factors in Uterine Serous Carcinomas: A Systematic Review.

Anna Svarna, Michalis Liontos, Alkistis Papatheodoridi

|Feb 13, 2025
Possible Prognostic Role of BMI Before Chemotherapy in the Outcomes of Women with Ovarian Cancer.

Stavroula A Paschou, Angeliki Andrikopoulou, Nikoletta Mili

|Dec 13, 2021
What Has Changed in the Management of Uterine Serous Carcinomas? Two Decades of Experience.

Michalis Liontos, Anna Svarna, Charalampos Theofanakis

|Dec 13, 2021
BRCA1/2 Mutation Types Do Not Affect Prognosis in Ovarian Cancer Patients.

Michalis Liontos, Eleni Zografos, Panagiotis Zoumpourlis

Pageof 1